1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Esophageal Achalasia Global Clinical Trials Review, H1, 2016

Esophageal Achalasia Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Esophageal Achalasia Global Clinical Trials Review, H1, 2016" provides an overview of Esophageal Achalasia clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal Achalasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Esophageal Achalasia Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Esophageal Achalasia to Gastrointestinal Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Esophageal Achalasia to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Prominent Drugs 19
Clinical Trial Profile Snapshots 20
Appendix 24
Abbreviations 24
Definitions 24
Research Methodology 25
Secondary Research 25
About GlobalData 26
Contact Us 26
Disclaimer 26
Source 27

List of Tables
Esophageal Achalasia Therapeutics, Global, Clinical Trials by Region, 2016* 5
Esophageal Achalasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Esophageal Achalasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Esophageal Achalasia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Esophageal Achalasia Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9
Esophageal Achalasia Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Esophageal Achalasia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Proportion of Esophageal Achalasia to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 12
Esophageal Achalasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Esophageal Achalasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Esophageal Achalasia to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 15
Esophageal Achalasia Therapeutics, Global, Clinical Trials by Phase, 2016* 16
Esophageal Achalasia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
Esophageal Achalasia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18
Esophageal Achalasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 19

List of Figures
Esophageal Achalasia Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Esophageal Achalasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Esophageal Achalasia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Proportion of Esophageal Achalasia to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 12
Esophageal Achalasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Esophageal Achalasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Esophageal Achalasia to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 15
Esophageal Achalasia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 16
Esophageal Achalasia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
Esophageal Achalasia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 19
GlobalData Methodology 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.